Abrdn Healthcare Investors (HQH) Research
Abrdn Healthcare Investors is a closed-end equity fund, stewarded by abrdn Inc. Its mandate involves global public equity investments, specifically targeting the healthcare sector, encompassing businesses in biotechnology, medical devices, and pharmaceuticals. The primary focus is on high-growth, small-capitalization companies. The portfolio is constructed using a fundamental analysis approach, scrutinizing companies based on their current or projected market position for products and services, the experience of their management teams, their technological prowess, and their capability to either self-fund growth or secure external financing. Its performance is measured against several benchmarks: the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Established on October 31, 1986, the fund is domiciled in the United States.
Market snapshot
- Symbol
- HQH
- Price
- $20.19
- Day change
- +1.46%
- Market cap
- $1.2B
- P/E ratio
- 4.28x
- 52-week range
- 15.09-20.46
- Sector
- Financial Services
- Industry
- Asset Management
Recent news
- 5 ‘Healthy' Dividends Paying Up To 14.1%
Healthcare dividend stocks are selling off with the turbulence in the Middle East.
Peer companies
Recent insider activity
- Mahai Chris LaVictoire — trade (0 shares) on 2026-06-09
- Reilly Heather Carter — trade (0 shares) on 2025-12-09
- Dietrick Joseph Francis — trade (0 shares) on 2025-07-17
- Hepp Robert W. — trade (0 shares) on 2025-03-11
- Gebauer Katie Lynn — trade (0 shares) on 2025-03-11
Open Abrdn Healthcare Investors (HQH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.